Investigation of Heart Failure Status Over Time Using Respiratory Parameters

ResMed

Status: Completed

Conditions: Sleep Apnea Syndromes; Heart Failure, Congestive

Treatments: Device: ApneaLink

Study type: Observational

Funder types: Industry

Identifiers

NCT00494117

X07- 0052

Details and patient eligibility

About

The purpose of the study is to investigate respiratory indicators for clinically important changes in Heart Failure status over time.

Enrollment: 50 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Moderate to severe Heart Failure (as determined by Echocardiogram or by treating physician)

Exclusion criteria

• Malignant disease affecting gas exchange or respiratory parameters
• Medications compromising breathing with no adverse affects on heart failure
• Clinically significant (moderate to severe) asthma requiring therapy
• Chronic parenchymal lung disease (FEV1/FVC ratio = 65% or as determined by the treating physician)
• Severe pulmonary hypertension
• Heart failure due to alcohol abuse or chemotherapy
• Narcotic abuse/intravenous drug use (including HIV+ and hepatitis C)
• Alcohol consumption > 80g/day
• Patients receiving home Oxygen
• Methicillin- resistant Staphylococcus aureus infection
• Narcolepsy
• Cataplexy
• Enrolled in any concurrent study, that may confound the results of this study.
• Inability or refusal to sign the Patient Consent Form
• Inability or refusal to adhere to protocol requirements